Indian markets face pressure from global corrections and FPI selling. Earnings are disappointing, and valuations are high. Pharma sector rallied despite potential US tariffs. Promoters offloaded shares, but retail investors provided support. Auto sector faces challenges from weak demand and potential tariff impacts. The India-UK FTA may benefit some sectors, but implementation details are awaited.